David Taube

6.0k total citations
151 papers, 4.5k citations indexed

About

David Taube is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, David Taube has authored 151 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Transplantation, 54 papers in Surgery and 43 papers in Nephrology. Recurrent topics in David Taube's work include Renal Transplantation Outcomes and Treatments (70 papers), Organ Transplantation Techniques and Outcomes (26 papers) and Renal Diseases and Glomerulopathies (23 papers). David Taube is often cited by papers focused on Renal Transplantation Outcomes and Treatments (70 papers), Organ Transplantation Techniques and Outcomes (26 papers) and Renal Diseases and Glomerulopathies (23 papers). David Taube collaborates with scholars based in United Kingdom, United States and Canada. David Taube's co-authors include Tom Cairns, Neill Duncan, Michelle Willicombe, Andrew Palmer, Adam McLean, Thomas Cairns, M. Bewick, Damien Ashby, Paul Brookes and Ken I. Welsh and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

David Taube

150 papers receiving 4.4k citations

Peers

David Taube
John J. Curtis United States
John D. Scandling United States
Jorge A. Velosa United States
Marian Klinger Poland
Giuseppe Segoloni Italy
K. Salmela Finland
R. Brunkhorst Germany
Gunnar Tydén Sweden
James A. Schulak United States
Douglas J. Norman United States
John J. Curtis United States
David Taube
Citations per year, relative to David Taube David Taube (= 1×) peers John J. Curtis

Countries citing papers authored by David Taube

Since Specialization
Citations

This map shows the geographic impact of David Taube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Taube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Taube more than expected).

Fields of papers citing papers by David Taube

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Taube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Taube. The network helps show where David Taube may publish in the future.

Co-authorship network of co-authors of David Taube

This figure shows the co-authorship network connecting the top 25 collaborators of David Taube. A scholar is included among the top collaborators of David Taube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Taube. David Taube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taube, David, et al.. (2024). Prostaglandin E2 affects mitochondrial function in adult mouse cardiomyocytes and hearts. Prostaglandins Leukotrienes and Essential Fatty Acids. 201. 102614–102614.
2.
Moran, Linda, et al.. (2020). Anticoagulant-Related Nephropathy in a Renal Transplant Recipient. Kidney International Reports. 5(11). 2089–2096. 3 indexed citations
3.
Regan, Fiona, et al.. (2016). Use of non‐irradiated blood components in Campath (alemtuzumab)‐treated renal transplant patients. Transfusion Medicine. 26(2). 138–146. 6 indexed citations
4.
McLaughlin, Laura, Irene Rebollo‐Mesa, H. Terence Cook, et al.. (2015). B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection. Kidney International. 88(3). 560–568. 31 indexed citations
5.
Rebollo‐Mesa, Irene, Terry Cook, Candice Roufosse, et al.. (2012). Chronic Antibody-Mediated Rejection: B-Cell Dependent Alloreactive IFN gamma-Producing CD4+ T Cells Could Be Used as a Biomarker To Determine Responsiveness to Therapy. American Journal of Transplantation. 12. 410–410. 1 indexed citations
6.
Willicombe, Michelle, Paul Brookes, Eva Santos‐Nunez, et al.. (2011). Outcome of Patients with Preformed Donor-Specific Antibodies Following Alemtuzumab Induction and Tacrolimus Monotherapy. American Journal of Transplantation. 11(3). 470–477. 42 indexed citations
7.
Willicombe, Michelle, Candice Roufosse, Paul Brookes, et al.. (2011). Antibody-Mediated Rejection After Alemtuzumab Induction: Incidence, Risk Factors, and Predictors of Poor Outcome. Transplantation. 92(2). 176–182. 41 indexed citations
8.
Lawrence, Christopher, Jack Galliford, Michelle Willicombe, et al.. (2011). Antibody Removal Before ABO-Incompatible Renal Transplantation: How Much Plasma Exchange Is Therapeutic?. Transplantation. 92(10). 1129–1133. 28 indexed citations
9.
Ashby, Damien, Daniel P. Gale, Mark Busbridge, et al.. (2009). Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney International. 75(9). 976–981. 250 indexed citations
10.
Power, Albert, Seema Singh, Damien Ashby, et al.. (2009). Translumbar central venous catheters for long-term haemodialysis. Nephrology Dialysis Transplantation. 25(5). 1588–1595. 34 indexed citations
11.
Borrows, Richard, Kakit Chan, Marina Loucaidou, et al.. (2006). Five Years of Steroid Sparing in Renal Transplantation with Tacrolimus and Mycophenolate Mofetil. Transplantation. 81(1). 125–128. 20 indexed citations
12.
Loucaidou, Marina, Richard Borrows, Sara E. Marshall, et al.. (2005). Cytokine Polymorphisms Do Not Influence Acute Rejection in Renal Transplantation Under Tacrolimus-Based Immunosuppression. Transplantation Proceedings. 37(4). 1760–1761. 22 indexed citations
13.
Borrows, Richard, Marina Loucaidou, Tom Cairns, et al.. (2004). Steroid Sparing with Tacrolimus and Mycophenolate Mofetil in Renal Transplantation. American Journal of Transplantation. 4(11). 1845–1851. 33 indexed citations
14.
Squifflet, Jean-Paul, Kerstin Claesson, K.-H. Dietl, et al.. (2001). DOSE OPTIMIZATION OF MYCOPHENOLATE MOFETIL WHEN ADMINISTERED WITH A LOW DOSE OF TACROLIMUS IN CADAVERIC RENAL TRANSPLANT RECIPIENTS. Transplantation. 72(1). 63–69. 114 indexed citations
15.
Lee, Janet, Thomas Cairns, William McKane, et al.. (1998). DEMONSTRATION OF IgM ANTIBODIES OF HIGH AFFINITY WITHIN THE ANTI-GAL??1-3GAL ANTIBODY REPERTOIRE. Transplantation. 66(8). 1117–1119. 12 indexed citations
16.
Vanrenterghem, Yves, J.P. Squifflet, John Forsythe, et al.. (1998). Co-administration of Tacrolimus and Mycophenolate Mofetil in Cadaveric Renal Transplant Recipients. Transplantation Proceedings. 30(4). 1290–1291. 28 indexed citations
17.
Gedroyc, Wladyslaw, et al.. (1992). Magnetic resonance angiography of renal transplants. The Lancet. 339(8796). 789–791. 50 indexed citations
18.
19.
Taube, David, et al.. (1983). Successful treatment of middle aged and elderly patients with end stage renal disease.. BMJ. 286(6383). 2018–2020. 39 indexed citations
20.
Brown, Christian, J S Cameron, D. Adu, et al.. (1983). High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial.. BMJ. 286(6371). 1097–1100. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John J. Curtis Breakdown of academic impact, for papers by John D. Scandling Breakdown of academic impact, for papers by Jorge A. Velosa Breakdown of academic impact, for papers by Marian Klinger Breakdown of academic impact, for papers by Giuseppe Segoloni Breakdown of academic impact, for papers by K. Salmela Breakdown of academic impact, for papers by R. Brunkhorst Breakdown of academic impact, for papers by Gunnar Tydén Breakdown of academic impact, for papers by James A. Schulak Breakdown of academic impact, for papers by Douglas J. Norman
Rankless by CCL
2026